Clicky

Viatris Inc.(VTRS)

Description: Viatris Inc., a healthcare company, develops, licenses, manufactures, markets, and distributes brand and generic drugs, complex generics, biosimilars, and active pharmaceutical ingredients (APIs) worldwide. The company operates through Developed Markets, Greater China, JANZ, and Emerging Markets segments. It offers drugs in various therapeutic areas, including infectious diseases and non-communicable diseases; HIV/AIDS; and oncology, immunology, endocrinology, ophthalmology, and dermatology, as well as antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas. The company provides medicines, such as Wixela, Inhub, ADVAIR DISKUS, glatiramer acetate injection, Copaxone, and over the counter products in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions; and support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. The company sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, and EpiPen auto-injector; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; Trastuzumab injection; and Celebrex and anti-retrovirals names, as well as offers biosimilars franchises, including Fulphila, Ogivri, and Hulio. Viatris Inc. has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. The company was founded in 1961 and is based in Canonsburg, Pennsylvania.


Keywords: Biotechnology S&P 500 Drugs Infectious Diseases Health Care Active Pharmaceutical Ingredients Biosimilar HIV/Aids Counter Products Trastuzumab Pharmaceutical Industry In Bangladesh Adalimumab Glatiramer Acetate Amitiza E Commerce Pharmacies Lyrica Pharmaceutical Retailers

Home Page: www.viatris.com

VTRS Technical Analysis

1000 Mylan Boulevard
Canonsburg, PA 15317
United States
Phone: 724 514 1800


Officers

Name Title
Mr. Robert J. Coury Exec. Chairman
Mr. Michael Goettler CEO & Exec. Director
Mr. Rajiv Malik Pres & Exec. Director
Mr. Sanjeev Narula Chief Financial Officer
Mr. Anthony Mauro Pres of Developed Markets
Mr. Sanjeev Kumar Sethi Chief Operating Officer
Mr. Paul B. Campbell Chief Accounting Officer, Sr. VP & Corp. Controller
Ms. Melissa Trombetta Head of Global Investor Relations
Mr. Brian S. Roman Global Gen. Counsel
Mr. David Bayles Chief Compliance Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 3.3535
Trailing PE: 17.9394
Price-to-Book MRQ: 0.6815
Price-to-Sales TTM: 0.8076
IPO Date: 2020-11-16
Fiscal Year End: December
Full Time Employees: 37000
Back to stocks